Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Daily News

CAS vs CEA Outcomes in Medicare Population Align With Clinical Trial Data

L.A. McKeown

April 28, 2016

News Conference News ISC 2016

ACT I, CREST Support Carotid Stenting as Alternative to Surgery, but Larger Question Looms

Todd Neale

February 17, 2016

Presentation ISET 2016

Understand CREST 2 and the Impact of the CREST 2 Registry

Presenter: Thomas Brott

February 07, 2016

News Daily News

Stroke Risk With Carotid Stenting Persists Over Time: Meta-Analysis

L.A. McKeown

November 01, 2015

News Daily News

Meta Análisis: El Riesgo de ACV con la Implantación de Stents Carotídeos se Mantiene con el Tiempo

L.A. McKeown

November 01, 2015

Presentation TCT 2015

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? Another Failed NIH-Funded Study: CREST-2 Is CORAL Redux (or Worse)!

Presenter: William A. Gray, D. Christopher Metzger

October 14, 2015

Presentation TCT 2015

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? The CREST-2 Trial Is the Right Trial at the Right Time!

Presenter: William A. Gray, D. Christopher Metzger, Gary S. Roubin

October 14, 2015

News Conference News TCT 2015

CREST-2 Triggers Spirited Debate on Merits of CAS vs. CEA

Todd Neale

October 14, 2015

News Daily News

Stroke Risk of Carotid Occlusion Appears Very Low in Contemporary Asymptomatic Patients

September 29, 2015

News Daily News

El Riesgo de ACV de las Oclusiones Carotídeas parece Muy Bajo en Pacientes Asintomáticos Contemporáneos

September 29, 2015

Presentation ISET 2014

CREST 2: What Could It Tell Us?

Presenter: Thomas Brott

January 19, 2014

Presentation TCT 2013

CREST 2: Designed to Answer the Critical Questions About the Asymptomatic Carotid Patient

Presenter: Gary Roubin

October 28, 2013

Advertisement

CAS vs CEA Outcomes in Medicare Population Align With Clinical Trial Data

ACT I, CREST Support Carotid Stenting as Alternative to Surgery, but Larger Question Looms

Understand CREST 2 and the Impact of the CREST 2 Registry

Stroke Risk With Carotid Stenting Persists Over Time: Meta-Analysis

Meta Análisis: El Riesgo de ACV con la Implantación de Stents Carotídeos se Mantiene con el Tiempo

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? Another Failed NIH-Funded Study: CREST-2 Is CORAL Redux (or Worse)!

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? The CREST-2 Trial Is the Right Trial at the Right Time!

CREST-2 Triggers Spirited Debate on Merits of CAS vs. CEA

Stroke Risk of Carotid Occlusion Appears Very Low in Contemporary Asymptomatic Patients

El Riesgo de ACV de las Oclusiones Carotídeas parece Muy Bajo en Pacientes Asintomáticos Contemporáneos

CREST 2: What Could It Tell Us?

CREST 2: Designed to Answer the Critical Questions About the Asymptomatic Carotid Patient

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content